The company’s revenue from operations increased by 31.49 per cent YoY, standing at Rs 996.42 crore in Q3 FY25 versus Rs 757 crore in Q3 FY24.

The company's revenue from operations in Q2 FY25 stood at Rs 1,325.05 crore, reflecting a 21.1 per cent increase from Rs 1,094.10 crore in the same quarter of the previous fiscal year.

This stock is more expensive than MRF. How a Single-Digit Share Value Soared to Six Figures in 4 Months!

In Q4, FIIs increased their stake, while ace investor Mukul Agrawal has consistently held a 1.06 per cent stake for the past eight quarters.

Shares of the company gained more than 150 per cent in the last six months.  

Over the past six months the company's shares have generated a stellar return of 75.54 per cent while during the same time frame BSE Healthcare has risen by 23.86 per cent

Shares of the company gained about 45 per cent in the last six months.

Shares have delivered multibagger returns of around 102 per cent over the last year!

Additionally, the company’s order book stands at Rs 1,108 crore which is 5.50 times of FY23 revenue. Out of the total order book, 87 per cent of orders are domestic orders and 13 per cent are export orders. Order Inflow in YTD FY24 stands at Rs 725 crore. These include orders from BDL, L&T and MoD (IAF) to be executed over the next 12-24 months. working towards securing more orders in defence and explosive segments.

the company’s profits increased by 35 per cent CAGR (Compound Annual Growth Rate)

Watch out for these large-cap stocks in Wednesday’s trading session!